Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases
Wellcome Trust (106917/Z/15/Z)
Lister Institute of Preventive Medicine (Prize Fellowship)
United States Agency for International Development (VAC054)
Received: 18 February 2019
Accepted: 24 August 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: See “InternalRef removed” section above for VAC054 ethics approval—section entitled “InternalRef removed”.
: Not applicable.
: SJD is a named inventor on patent applications relating to malaria vaccines and immunization regimens. SD has a patent on the FMP2.1 vaccine antigen.